ʻO SARS-CoV-2 IgM/IgG hōʻike kit(Colloidal Gold)
ʻO ka wehewehe ʻana i ka pahu:
ʻO ka ʻike kūpono a me ka hoʻokaʻawale ʻana o nā antibodies IgM a me IgG i ka SARS-CoV-2 i ka serum, plasma (EDTA, sodium citrate a me lithium heparin) a i ʻole ka manamana lima koko holoʻokoʻa, nā ʻāpana koko holoʻokoʻa mai nā mea maʻi i manaʻo ʻia he maʻi COVID-19 e kahi mea mālama ola.
ʻO ka ʻike kūpono a me ka hoʻokaʻawale ʻana o nā antibodies IgM a me IgG i ka SARS-CoV-2 i ka serum, plasma (EDTA, sodium citrate a me lithium heparin) a i ʻole ka manamana lima koko holoʻokoʻa, nā ʻāpana koko holoʻokoʻa mai nā mea maʻi i manaʻo ʻia he maʻi COVID-19 e kahi mea mālama ola.
Hōʻike
1T/Kiki,20T/Kiki
Nā hiʻohiʻona & pono
■Hoʻopili ʻia me ka Nucleocapsid kikoʻī i koho ʻia a me Spike protein antigen.
■ Ka ike no ka IgM a me IgG antibodies i ka manawa like.
■ Hana maʻalahi, wehewehe maʻalahi ka hopena.
■ Hoao wikiwiki i loko o 15 minuke.
Nā hana hōʻikeʻike
- Kuikahi pākēneka maikaʻi(PPA)=91.07%(153/168)(95% Cl:85.70%-94.92%).
- Kuikahi pākēneka ʻino(NPA)=95.37%(103/108)(95% Cl:89.53%-98.48%).
- Ka huina holoʻokoʻa o ka ʻaelike(ORA)=92.75%((153+103)/(168+108))(95% Cl:89.03%-95.52%).
Waihona
1. ʻO ka mea ho'āʻo he maʻalahi i ka haʻahaʻa a me ka wela.
2. E mālama i nā ʻāpana pahu ma 2-30℃a mai hoʻohana ma hope o ka lā pau ma ka pahu lepili waho.
